Multiple Myeloma Treatment in Istanbul: Advanced Hematology Care

Istanbul's JCI-accredited hematology centers offer comprehensive multiple myeloma treatment — from VRd induction and daratumumab-based regimens to autologous stem cell transplant and CAR-T cell therapy — at 60-70% lower cost than the UK, following ESMO and IMWG guidelines.

How much does multiple myeloma treatment cost in Istanbul?

VRd induction (4-6 cycles) costs $12,000–$20,000 in Istanbul versus £30,000–£60,000 in the UK. Autologous stem cell transplant costs $20,000–$40,000 versus £50,000–£100,000. Daratumumab costs $3,000–$6,000 per cycle versus £8,000–£15,000. Over a full treatment course, patients save $50,000–$100,000 compared to UK private treatment.

Induction therapy: VRd and daratumumab-based regimens

The standard induction regimen for newly diagnosed multiple myeloma is VRd (bortezomib, lenalidomide, dexamethasone), which achieves complete response in 30-40% of patients. For high-risk patients, daratumumab-based regimens (Dara-VRd) are preferred, showing superior progression-free survival in clinical trials.

Autologous stem cell transplant for myeloma in Istanbul

After 4-6 cycles of induction, eligible patients proceed to autologous stem cell transplant (ASCT) with high-dose melphalan conditioning. Istanbul centers perform ASCT in dedicated BMT units with HEPA-filtered isolation rooms. Complete response rates after ASCT reach 40-60%, significantly improving long-term outcomes.

Relapsed/refractory myeloma: carfilzomib, pomalidomide, CAR-T

For relapsed or refractory multiple myeloma, Istanbul centers offer carfilzomib-based combinations (KRd, DKRd), pomalidomide-based regimens, selinexor, and CAR-T cell therapy (idecabtagene vicleucel, ciltacabtagene autoleucel) at select centers. Bispecific antibodies (teclistamab) are also available.

Molecular testing and risk stratification

Istanbul oncologists perform comprehensive molecular testing: FISH cytogenetics for high-risk features (del17p, t(4;14), t(14;16), 1q21 gain), serum protein electrophoresis, free light chain assay, and bone marrow biopsy with flow cytometry. High-risk patients receive intensified treatment protocols.

How to start multiple myeloma treatment in Istanbul

Send your bone marrow biopsy pathology report, FISH cytogenetics results, serum protein electrophoresis, free light chain assay, and imaging (PET-CT or whole-body MRI) to our coordination team. Istanbul's hematology tumor board will review your case and provide a treatment plan within 48-72 hours.